Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
basal-cell-carcinomaskin-cancer
basal cell carcinoma (bcc), first line treatment, bcc, skin cancer, basal cell carcinoma, anti-pd-1 monoclonal antibody, hhi naïve, cemiplimab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 813639
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.